| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fingolimod Hydrochloride | FAERS: 3 | US FAERS | |
| 2 | Bosentan | FAERS: 2 | US FAERS | |
| 3 | Sofosbuvir | FAERS: 2 | US FAERS | |
| 4 | Tenofovir | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Zoledronic Acid | FAERS: 2 | US FAERS | |
| 6 | ledipasvir, sofosbuvir drug combination | FAERS: 2 | US FAERS | |
| 7 | 2-[(E)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid;(2S)-2,6-diaminohexanoic acid | FAERS: 1 | US FAERS | |
| 8 | Cytarabine | FAERS: 1 | US FAERS | |
| 9 | Dabigatran | FAERS: 1 | US FAERS | |
| 10 | Deferasirox | FAERS: 1 | OFFSIDES US FAERS | |
| 11 | Droxidopa | FAERS: 1 | US FAERS | |
| 12 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 13 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 14 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 15 | Imatinib Mesylate | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 16 | Isotretinoin | FAERS: 1 | US FAERS | |
| 17 | Norgestrel | FAERS: 1 | US FAERS | |
| 18 | Sorafenib | FAERS: 1 | US FAERS | |
| 19 | Tenofovir | FAERS: 1 | OFFSIDES US FAERS | |
| 20 | Teriparatide | FAERS: 1 | US FAERS | |
| 21 | Topiramate | FAERS: 1 | US FAERS | |
| 22 | Viekira Pak | FAERS: 1 | US FAERS | |
| 23 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 24 | Amphetamine | OFFSIDES | ||
| 25 | Bupropion | OFFSIDES | ||
| 26 | Dapsone | OFFSIDES | ||
| 27 | Etoposide | OFFSIDES | ||
| 28 | Ezetimibe | Canada Vigilance: 1 | Canada Vigilance | |
| 29 | Oseltamivir | OFFSIDES | ||
| 30 | Potassium | OFFSIDES | ||
| 31 | Valganciclovir | OFFSIDES | ||
| 32 | chlorhexidine gluconate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.